Boronic ester and acid compounds, synthesis and uses
AssigneeMillennium Pharmaceuticals, Inc.
InventorsJulian Adams, Yu-Ting Ma, Ross Stein, Matthew Baevsky, Louis Grenier, Louis Plamondon
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a method for reducing the rate of degradation of proteins in an animal comprising contacting cells of the animal with certain boronic ester and acid compounds. Also disclosed herein are novel boronic ester and acid compounds, their synthesis and uses.
Claims26
A method for inhibiting HIV replication in an animal in need of said inhibiting, comprising administering to said animal an effective amount of a proteasome inhibitor of formula (1b)
- 52
- or a pharmaceutically acceptable salt thereof;
- wherein
- P10 is selected from the group consisting of R7—C(O)—, R7—SO2—, R7—NH—C(O)—, and R7—O—C(O)—, where R7 is selected from the group consisting of alkyl, cycloalkyl, aryl, and aralkyl;
- B11 is independently one of N or CH;
- X11, at each occurrence, is independently one of —C(O)—NH—, —CH2—NH—, —CH(OH)—CH2, —CH(OH)—CH(OH)—, —CH(OH)—H2—NH—, —CH═CH—, —C(O)—CH2—, —SO2—NH—, —SO2—CH2— or —CH(OH)—CH2—C(O)—NH—, provided that when B11 is N, then X11 is —C(O)—NH—;
- X12 is one of —C(O)—NH—, —CH(OH)—CH2, —CH(OH)—CH(OH)—, —C(O)—CH2—, —SO2—NH—, —SO2—CH2— or —CH(OH)—CH2—C(O)—NH—;
- R10 is hydrogen or alkyl, or R10 forms together with the adjacent R11, or when A10 is zero, forms together with the adjacent R12, a nitrogen-containing mono-, bi- or tri-cyclic, saturated or partially saturated ring system having 4-14 ring members, that can be optionally substituted by one or two of keto, hydroxy, alkyl, aryl, aralkyl, alkoxy or aryloxy;
- R11, at each occurrence, is independently one of hydrogen, alkyl, cycloalkyl, aryl, a 5-10 membered saturated, partially unsaturated or aromatic heterocycle or —CH2—R15, where the ring portion of said aryl or heterocycle can be optionally substituted;
- R12 and R13 are each independently one of hydrogen, alkyl, cycloalkyl, aryl, a 5-10 membered saturated, partially unsaturated or aromatic heterocycle or —CH2—R15, where the ring portion of said aryl or heterocycle can be optionally substituted;
- R15 is phenyl, aralkyl, cycloalkyl, or -chalcogen-alkyl, where the ring portion of said phenyl or aralkyl can be optionally substituted;
- Z11 and Z12 are independently alkyl, hydroxy, alkoxy, or aryloxy, or together Z11 and Z12 form a moiety derived from a dihydroxy compound having at least two hydroxy groups separated by at least two connecting atoms in a chain or ring, said chain or ring comprising carbon atoms and, optionally, a heteroatom or heteroatoms which can be N, S, or O;
- and
- A10 is 0, 1, or 2.
A method for inhibiting HIV replication in an animal in need of said inhibiting, comprising administering to said animal an effective amount of a proteasome inhibitor of formula (1b)
- 53
- or a pharmaceutically acceptable salt thereof;
- wherein
- P10 is selected from the group consisting of R7—C(O)—, R7—SO2—, R7—NH—C(O)—, and R7—O—C(O)—, where R7 is selected from the group consisting of alkyl, cycloalkyl, aryl, and aralkyl;
- B11 is CH;
- each of X11 and X12 is —C(O)—NH—;
- R10 is hydrogen or alkyl;
- R11, at each occurrence, is independently one of hydrogen, alkyl, cycloalkyl, aryl, a 5-10 membered saturated, partially unsaturated or aromatic heterocycle or —CH2—R15, where the ring portion of said aryl or heterocycle can be optionally substituted;
- R12 and R13 are each independently one of hydrogen, alkyl, cycloalkyl, aryl, a 5-10 membered saturated, partially unsaturated or aromatic heterocycle or —CH2—R15, where the ring portion of said aryl or heterocycle can be optionally substituted;
- R15 is phenyl, aralkyl, cycloalkyl, or -chalcogen-alkyl, where the ring portion of said phenyl or aralkyl can be optionally substituted;
- Z11 and Z12 are independently alkyl, hydroxy, alkoxy, or aryloxy, or together Z11 and Z12 form a moiety derived from a dihydroxy compound having at least two hydroxy groups separated by at least two connecting atoms in a chain or ring, said chain or ring comprising carbon atoms and, optionally, a heteroatom or heteroatoms which can be N, S, or O;
- and
- A10 is 0, 1, or 2.
Dependencies are inferred from the claim text.